Search
for
Sort by
Research 61–90 of 1000+
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- The Role of Tofacitinib in the Management of Alopecia Totalis
- Alopecia universalis. Partial response to tofacitinib
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- Prenatal diagnosis of a foetus with partial monosomy 4p and partial trisomy 13q
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Reply to early onset effluvium secondary to COVID-19 and body-hair effluvium
- Alopecia Areata Barbae in a Nutshell
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Topical tofacitinib in treatment of alopecia areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Alopecia Universalis: Never Give Up?
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Biologics in the management of childhood atopic dermatitis
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- A Successful Treatment of Alopecia Universalis with Ruxolitinib
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years